With the future of the EU HTA Regulation in question, Niklas Hedberg, Chair of the EUnetHTA Executive Board, discusses what’s needed to get the HTA Proposal back on track. Recorded at the HTAi conference in Köln, Niklas also expresses his opinions on the state of the OMP legislation from the standpoint of both EUnetHTA and his home HTA in Sweden, and does so incorporating the discussions around the orphan legislation at the conference.

Niklas Hedberg is the Chief Pharmacist of the Swedish Pharmaceutical Benefits Agency (TLV) and a frequent presenter at leading conferences such as DIA and ISPOR. He is seen as one of Europe’s young visionaries, working to develop new approaches to evaluating medicines in the member states while also improving access for patients.

With the future of the EU HTA Regulation in question, Niklas Hedberg, Chair of the EUnetHTA Executive Board, discusses what’s needed to get the HTA Proposal back on track. Recorded at the HTAi conference in Köln, Niklas also expresses his opinions on the state of the OMP legislation from the standpoint of both EUnetHTA and his home HTA in Sweden, and does so incorporating the discussions around the orphan legislation at the conference.<br> <br>Niklas Hedberg is the Chief Pharmacist of the Swedish Pharmaceutical Benefits Agency (TLV) and a frequent presenter at leading conferences such as DIA and ISPOR. He is seen as one of Europe’s young visionaries, working to develop new approaches to evaluating medicines in the member states while also improving access for patients.

Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast.  Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.

<p>Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast.  Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.</p>

Duane Schulthess, Managing Director of Vital Tran…

Vital Health Podcast

With the future of the EU HTA Regulation in quest…

Advertisement